PatientFiles: psoriasis
Cyndi Lauper talks to PharmaTimes about her experiences with psoriasis
PharmaTimes Magazine Archive
Magazine highlights
View more from the latest edition
SmartPeople: Jennifer Turgiss
Jennifer Turgiss provides an insight into her role as vice president, behaviour science and advanced analytics, at Johnson & Johnson
Class of 2019
A high proportion of this year’s Drugs to Watch list address rare and orphan diseases
Mapping tumours – a new direction for cancer treatment
A team from the National Physical Laboratory (NPL) is developing a ‘Google Earth’ of cancer, revealing insights on a molecular scale to guide the development of more efficient drugs to target tumours. Josephine Bunch, principal investigator of the Rosetta project, offers an insight into this promising area of cancer research
A helping hand
Is augmented intelligence the key to achieving true digital transformation in pharma? Peter Crane outlines the need for a scientist-centric approach
A new horizon
The future of AI in pharma and wider healthcare is unfolding right now – never has the crystal ball of science found itself so resolutely in the present. If we dare to glance at the horizon, however, we will see the dreamscape of an era-defining healthcare system and pharma industry, transformed by the stunning possibilities of AI
Oncology needs talent
Pharma’s traditional R&D path is a business model under pressure. The ever-increasing demand for talented leadership in oncology is driving a need for collaboration
Sticking to it
In an age where medication adherence apps are the contemporary equivalent of ‘a pill for every ill’, a fresh approach is desperately needed to break through the oversaturated market.
